Mr. Christopher Hopton reports

SIRONA BIOCHEM ANNOUNCES LOAN

Sirona Biochem Corp. has entered into a demand grid promissory note with 0906462 B.C. Ltd. for a loan in the aggregate principal amount of up to $1-million. Pursuant to the terms and conditions of the note:

1. The loan is repayable on demand by the lender;
2. The loan bears interest at a rate of 12 per cent per year, calculated yearly not in advance;
3. The company has agreed to, subject to TSX Venture Exchange approval, issue to the lender 450,000 common shares in the capital of the company at a price of 12 cents per bonus share as consideration for the risks taken by the lender in providing the loan to the company.

The bonus shares, if and when issued, will be subject to a statutory hold period of four months and one day from the date of issuance, in accordance with applicable securities legislation.

The lender is wholly owned by Dr. Howard Verrico, a director and officer of the company. Accordingly, the loan constitutes a related party transaction, as defined in Multilateral Instrument 61-101 -- Protection of Minority Security Holders in Special Transactions. The company is relying on exemptions from the formal valuation and minority shareholder approval requirements, pursuant to subsections 5.5(a) and 5.7(1)(a) of MI 61-101, respectively, for the loan, as the value of the loan does not represent more than 25 per cent of the company's market capitalization, as determined in accordance with MI 61-101.

About Sirona Biochem Corp.

Sirona is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.

Sirona's compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and continuing royalty payments. Sirona's laboratory, TFChem, is in France and is the recipient of multiple French national scientific awards as well as European Union and French government grants.

We seek Safe Harbor.